Pages that link to "Q35009558"
Jump to navigation
Jump to search
The following pages link to Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine (Q35009558):
Displaying 50 items.
- Vaccines: from empirical development to rational design (Q21089599) (← links)
- A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses (Q21135240) (← links)
- Immune modulation during latent herpesvirus infection (Q24624044) (← links)
- HIV-1 prophylactic vaccines: state of the art (Q26740042) (← links)
- Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway (Q26745798) (← links)
- Targeting the latent reservoir to achieve functional HIV cure (Q26745923) (← links)
- HIV-Host Interactions: Implications for Vaccine Design (Q26765966) (← links)
- Recent update in HIV vaccine development (Q26766628) (← links)
- Animal Models for HIV Cure Research (Q26767476) (← links)
- Role of HLA Adaptation in HIV Evolution (Q26772713) (← links)
- Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions (Q26777442) (← links)
- Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs (Q26781511) (← links)
- Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies (Q26825814) (← links)
- A Blueprint for HIV Vaccine Discovery (Q26829865) (← links)
- A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine (Q26830360) (← links)
- Using epigenetics to define vaccine-induced memory T cells (Q26849423) (← links)
- Human memory T cells: generation, compartmentalization and homeostasis (Q26851748) (← links)
- Nonhuman primate models for HIV/AIDS vaccine development (Q26861148) (← links)
- Using nonhuman primates to model HIV transmission (Q26861425) (← links)
- Mechanisms of HIV protein degradation into epitopes: implications for vaccine design (Q26866505) (← links)
- Immune responses to HCV and other hepatitis viruses (Q26866955) (← links)
- HIV therapeutic vaccines: moving towards a functional cure (Q27002180) (← links)
- Clinical development of candidate HIV vaccines: different problems for different vaccines (Q27005008) (← links)
- Host-pathogen interaction in HIV infection (Q27009024) (← links)
- Profiling immunity to HIV vaccines with systems biology (Q27010629) (← links)
- Old and new: recent innovations in vaccine biology and skin T cells (Q27013570) (← links)
- SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans (Q27014903) (← links)
- Challenges in mucosal HIV vaccine development: lessons from non-human primate models (Q27022152) (← links)
- Hidden memories: frontline memory T cells and early pathogen interception (Q27022562) (← links)
- A global approach to HIV-1 vaccine development (Q27024614) (← links)
- Cell-mediated immunity to human CMV infection: a brief overview (Q27026981) (← links)
- Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge (Q27301021) (← links)
- A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen (Q27302081) (← links)
- Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C (Q27306437) (← links)
- DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques (Q27316075) (← links)
- Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge (Q27318151) (← links)
- AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity (Q27318266) (← links)
- CD8 T cell response maturation defined by anentropic specificity and repertoire depth correlates with SIVΔnef-induced protection (Q27321448) (← links)
- High avidity CD8 T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function (Q27323727) (← links)
- Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine (Q27334460) (← links)
- Treatment with IL-7 prevents the decline of circulating CD4 T cells during the acute phase of SIV infection in rhesus macaques (Q27346577) (← links)
- New concepts in HIV-1 vaccine development (Q28067027) (← links)
- Exploiting viral natural history for vaccine development (Q28081817) (← links)
- The prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation' (Q28088338) (← links)
- Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool (Q28390218) (← links)
- Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques (Q28540858) (← links)
- Inhibitory potential of subpopulations of CD8 T cells in HIV-1-infected elite suppressors (Q28710569) (← links)
- Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques (Q28830298) (← links)
- Immune-correlates analysis of an HIV-1 vaccine efficacy trial (Q29617377) (← links)
- Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? (Q30362489) (← links)